Hod-Hasharon, Israel

Ayelet Altman

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ayelet Altman: Innovator in Pharmaceutical Solutions

Introduction

Ayelet Altman is a prominent inventor based in Hod-Hasharon, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating multiple sclerosis. With a total of three patents to her name, Altman continues to push the boundaries of medical innovation.

Latest Patents

Among her latest patents is a reduced volume formulation of glatiramer acetate and methods of administration. This invention focuses on a method for reducing the frequency of relapses in patients afflicted with relapsing-remitting multiple sclerosis (RRMS). The method involves administering 0.5 ml of an aqueous pharmaceutical solution containing 20 mg of glatiramer acetate and 20 mg of mannitol. Another notable patent is an improved injection assisting device, which features an injection lock indicator designed to inform users about the locking state of the device. This innovation enhances user experience by providing a clear visual contrast and ensuring safety during administration.

Career Highlights

Ayelet Altman is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to collaborate with other talented professionals in the industry, further advancing her research and innovations.

Collaborations

Some of her notable coworkers include Doris Saltkill and Tomer El-Gad. Their collaborative efforts contribute to the success of the projects they undertake together.

Conclusion

Ayelet Altman is a remarkable inventor whose work in pharmaceutical formulations is making a significant impact on the treatment of multiple sclerosis. Her innovative patents and collaborations highlight her dedication to improving patient care and advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…